Literature DB >> 23244553

Pregnant and non-pregnant women with substance use disorders: the gap between treatment need and receipt.

Mishka Terplan1, Erica J McNamara, Margaret S Chisolm.   

Abstract

Differences in pregnant and non-pregnant women's alcohol and drug use, substance treatment need, and treatment receipt were examined using The National Survey of Drug Use and Health (2002-2006). Treatment need and receipt were defined by either self-report or DSM-IV criteria. Pregnant women were less likely to use alcohol and drugs than non-pregnant women. Among women who use drugs, pregnant women were more likely to need treatment (odds ratio (OR) = 1.92; 95% confidence interval (CI): 1.46, 2.52), however they were not more likely to receive treatment (OR = 0.90; 95% CI: 0.54, 1.51). Overall, there is an unmet need for treatment among reproductive-aged substance users.

Entities:  

Mesh:

Year:  2012        PMID: 23244553     DOI: 10.1080/10550887.2012.735566

Source DB:  PubMed          Journal:  J Addict Dis        ISSN: 1055-0887


  18 in total

1.  Cannabis use among women of reproductive age in the United States: 2002-2017.

Authors:  Omayma Alshaarawy; James C Anthony
Journal:  Addict Behav       Date:  2019-08-07       Impact factor: 3.913

Review 2.  Sex and gender differences in substance use disorders.

Authors:  R Kathryn McHugh; Victoria R Votaw; Dawn E Sugarman; Shelly F Greenfield
Journal:  Clin Psychol Rev       Date:  2017-11-10

Review 3.  Epidemiology of substance use in reproductive-age women.

Authors:  R Kathryn McHugh; Sara Wigderson; Shelly F Greenfield
Journal:  Obstet Gynecol Clin North Am       Date:  2014-06       Impact factor: 2.844

Review 4.  Developmental opioid exposures: Neurobiological underpinnings, behavioral impacts, and policy implications.

Authors:  Samantha S Goldfarb; Gregg D Stanwood; Heather A Flynn; Devon L Graham
Journal:  Exp Biol Med (Maywood)       Date:  2019-10-20

5.  Correlates of Pregnant Women's Participation in a Substance Use Assessment and Counseling Intervention Integrated into Prenatal Care.

Authors:  Kelly C Young-Wolff; Lue-Yen Tucker; Mary Anne Armstrong; Amy Conway; Constance Weisner; Nancy Goler
Journal:  Matern Child Health J       Date:  2020-04

Review 6.  Role of Exogenous Progesterone in the Treatment of Men and Women with Substance Use Disorders: A Narrative Review.

Authors:  MacKenzie R Peltier; Mehmet Sofuoglu
Journal:  CNS Drugs       Date:  2018-05       Impact factor: 5.749

7.  Addiction and Depression: Unmet Treatment Needs Among Reproductive Age Women.

Authors:  Caitlin E Martin; Anna Scialli; Mishka Terplan
Journal:  Matern Child Health J       Date:  2020-05

8.  Health insurance, alcohol and tobacco use among pregnant and non-pregnant women of reproductive age.

Authors:  Qiana L Brown; Deborah S Hasin; Katherine M Keyes; David S Fink; Orson Ravenell; Silvia S Martins
Journal:  Drug Alcohol Depend       Date:  2016-07-12       Impact factor: 4.492

9.  Development and implementation of a screen-and-refer approach to addressing maternal depression, substance use, and intimate partner violence in home visiting clients.

Authors:  Sarah Dauber; Tiffany John; Aaron Hogue; Jessica Nugent; Gina Hernandez
Journal:  Child Youth Serv Rev       Date:  2017-07-25

Review 10.  Substance use in pregnancy: The medical challenge.

Authors:  Kerry-Ann Louw
Journal:  Obstet Med       Date:  2018-03-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.